Glen Ferguson

Glen has over 20 years of experience in the Biotechnology and Molecular Diagnostics Industries, within both startup and large, multinational corporations. Over the course of his career, Glen has developed significant experience in advancing business growth for companies driven by leading-edge technologies and services within various therapeutic areas. Most recently as Vice President, Corporate Development at HealthTell, Glen developed and led strategic growth initiatives driving the personalized medicine offering to the Pharmaceutical Industry. Previously, he held senior positions at ApoCell, where he was Vice President, Molecular Biomarkers, Beckman Coulter, Genaissance Pharmaceuticals, and Bristol Myers Squibb, amongst others. Glen holds a BS in Biology from the College of Charleston, and an MBA from the University of North Carolina, Greensboro.